Jean-Francois Baurain (Jean-François Baurain)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Placebo Controlled

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Acta clinica Belgica

This page only lists publications with an associated author ORCID identifier.

Publications

Julien Pierrard, Emmanuel Seront, Rachel Galot, Idil Gunes Tatar, Jean-Francois Baurain, Dario Di Perri
Regression of a melanoma brain metastasis that had appeared after immune checkpoint inhibitor discontinuation: a hypothesis-generating case. Acta clinica Belgica (2023)
C Mircea S Tesileanu, Marc Sanson, Wolfgang Wick, Alba A Brandes, Paul M J Clement, Sara C Erridge, Michael A Vogelbaum, Anna K Nowak, Jean-Francois Baurain, Warren P Mason, Helen Wheeler, Olivier Louis Chinot, Sanjeev Gill, Matthew Griffin, Leland Rogers, Walter Taal, Roberta Rudà, Michael Weller, Catherine McBain, Myra E van Linde, Kenneth D Aldape, Robert B Jenkins, Johan M Kros, Pieter Wesseling, Andreas von Deimling, Youri Hoogstrate, Iris de Heer, Peggy N Atmodimedjo, Hendrikus Jan Dubbink, Rutger W W Brouwer, Wilfred F J Van IJcken, Kin Jip Cheung, Vassilis Golfinopoulos, Brigitta G Baumert, Thierry Gorlia, Pim J French, Martin J Van Den Bent
Temozolomide and Radiotherapy versus Radiotherapy Alone in Patients with Glioblastoma, IDH-wildtype: Post Hoc Analysis of the EORTC Randomized Phase III CATNON Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (12) (2022)
James F Spicer, Aurélien Marabelle, Jean-Francois Baurain, Nina Louise Jebsen, Dag Erik Jøssang, Ahmad Awada, Rebecca S Kristeleit, Delphine Loirat, George Lazaridis, Christiane Jungels, Paal Brunsvig, Berit Nicolaisen, Andrew Saunders, Hamina Patel, Jerome Galon, Fabienne Hermitte, Ketil André Camilio, Brynjar Mauseth, Vibeke Sundvold, Baldur Sveinbjørnsson, Øystein Rekdal
Safety, Antitumor Activity, and T-cell Responses in a Dose-Ranging Phase I Trial of the Oncolytic Peptide LTX-315 in Patients with Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (10) (2021)